drugset / Trial / NCT01064089
Dose Escalation of HSP990 in Japan/Korea
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is a phase I dose escalation, multi-center, open-label study of HSP990 administered orally once weekly in adult Japanese and Korea patients with advanced solid malignancies.
Timeline
- Start
- 2010-02
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSP990 | Unknown | — | Oral |